Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

NEW YORK (Reuters Health) - Substances isolated from bitter melon, a plant eaten and used medicinally in much of Asia, could provide the basis of new drugs for treating diabetes and obesity, an ...

Where bitter melon shows the strongest promise is in diabetes management. It contains several bioactive compounds—charantin (a plant steroid), polypeptide-p (a plant-derived insulin-like protein) and ...